Skip to main content
. 2021 Nov 3;13(11):1851. doi: 10.3390/pharmaceutics13111851

Figure 5.

Figure 5

Total protein (A) and Lactate dehydrogenase (LDH) activity (B) in BALF, from various groups, namely normal control (NC), disease control (DC), inhalation therapy of pristine naringin (NAR), and liposomal naringin (L-NAR) (n = 12). *, and *** indicate significant difference by Newman–Keuls analysis after ANOVA at 95 percent confidence level at p < 0.05, and p < 0.001 respectively.